Logo
P

Pliant Therapeutics

136 employees

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
fibrosis
integrins
muscle biology
muscular dystrophy
Duchenne muscular dystrophy
Health Diagnostics
Health Care
Recruiting
oncology
Primary sclerosing cholangitis
Therapeutics
Idiopathic pulmonary fibrosis

Date founded

2015

Funding rounds raised

Total raised

$100M

from 13 investors over 13 rounds

P

Pliant Therapeutics raised $100M on March 3, 2020

Investors: S-Cubed Capital, Menlo Ventures, Redmile Group, Eventide Asset Management, Surveyor Capital, Logos Global Management, LP and Farallon Capital Management

P

Pliant Therapeutics raised $62M on July 16, 2018

Investors: S-Cubed Capital, Agent Capital, Menlo Ventures and Eventide Asset Management

P

Pliant Therapeutics raised $45M on February 18, 2016

Investors: pH Pharma Co., Ltd. and Third Rock Ventures

FAQ